← All trials
NCT04969679
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 16, 2018
- Primary completion
- Jun 3, 2020
- Completion date
- Jun 3, 2020
- First posted
- Jul 21, 2021
- Last posted
- Jul 21, 2021
- Enrollment
- 134
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Kangbuk Samsung HospitalLead sponsor
- Kangbuk Samsung HospitalReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.